X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
index medicus (21) 21
melanoma (18) 18
immunotherapy (16) 16
ipilimumab (16) 16
oncology (16) 16
melanoma - drug therapy (13) 13
antibodies, monoclonal - therapeutic use (12) 12
male (11) 11
cancer (10) 10
hematology, oncology and palliative medicine (10) 10
aged (9) 9
metastasis (9) 9
middle aged (9) 9
adult (8) 8
care and treatment (8) 8
skin neoplasms - drug therapy (8) 8
female (7) 7
surgery (7) 7
melanoma - pathology (6) 6
metastatic melanoma (6) 6
safety (6) 6
therapy (6) 6
aged, 80 and over (5) 5
antibodies, monoclonal - adverse effects (5) 5
melanoma - immunology (5) 5
skin neoplasms - pathology (5) 5
antigens (4) 4
clinical trials (4) 4
double-blind method (4) 4
drug dosages (4) 4
melanoma - secondary (4) 4
nivolumab (4) 4
patients (4) 4
research (4) 4
skin neoplasms - immunology (4) 4
studies (4) 4
survival (4) 4
adolescent (3) 3
analysis (3) 3
antibodies (3) 3
antibodies, monoclonal - administration & dosage (3) 3
antibody (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic agents - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
chemotherapy (3) 3
ctla-4 blockade (3) 3
dermatology (3) 3
disease progression (3) 3
health aspects (3) 3
lymphatic metastasis (3) 3
medical colleges (3) 3
melanoma - mortality (3) 3
melanoma - surgery (3) 3
monoclonal antibodies (3) 3
neoplasms - therapy (3) 3
pembrolizumab (3) 3
t-cell responses (3) 3
treatment outcome (3) 3
tumors (3) 3
young adult (3) 3
abridged index medicus (2) 2
adjuvants, immunologic (2) 2
animals (2) 2
anti-pd-1 (2) 2
antibodies, monoclonal (2) 2
antibodies, monoclonal, humanized - therapeutic use (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents, immunological - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
anti–pd-1 (2) 2
autoimmunity (2) 2
brain (2) 2
brain neoplasms - secondary (2) 2
cancer patients (2) 2
clinical trials as topic (2) 2
combination (2) 2
combined modality therapy (2) 2
ctla-4 (2) 2
cytotoxicity (2) 2
disease-free survival (2) 2
dose-response relationship, drug (2) 2
drug resistance, neoplasm (2) 2
drug therapy (2) 2
follow-up studies (2) 2
hospitals (2) 2
lymphatic system (2) 2
lymphocyte-associated antigen-4 (2) 2
malignant-melanoma (2) 2
medical research (2) 2
medicine & public health (2) 2
melanomas (2) 2
metastases (2) 2
monoclonal-antibody (2) 2
mutation (2) 2
neoplasm recurrence, local (2) 2
neoplasm staging (2) 2
node-positive melanoma (2) 2
oncology, experimental (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 908 - 918
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9948, pp. 1109 - 1117
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 522 - 530
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 92, Issue 2, pp. 368 - 375
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 2, pp. 293 - 295
Journal Article
Journal Article